Cardiac troponin T elevation after stroke: relationships between elevated serum troponin T, stroke location, and

Hwa-Suk Song1, Jang-Hyun Back, Dong-Kwan Jin

  • 1Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Elevated cardiac troponin T (cTnT) in acute ischemic stroke patients indicates more severe strokes and poorer outcomes. This finding highlights a potential link between cardiac damage and stroke severity, warranting further investigation.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarkers

Background:

  • Serum cardiac troponin T (cTnT) elevation typically indicates acute coronary syndrome.
  • The presence of elevated cTnT in acute ischemic stroke (AIS) patients is known, but its clinical significance remains unclear.
  • Understanding the relationship between elevated cTnT and AIS is crucial for prognosis.

Purpose of the Study:

  • To investigate the association between elevated serum cTnT levels and stroke severity in AIS patients.
  • To determine the correlation between elevated cTnT and the location of the ischemic event.
  • To identify the impact of elevated cTnT on the short-term prognosis of AIS.

Main Methods:

  • A cohort of 455 consecutive AIS patients admitted within 3 days of symptom onset was analyzed.
  • Patients were confirmed for AIS via diffusion-weighted magnetic resonance imaging.
  • The study compared outcomes between an elevated cTnT group (n=45) and a normal cTnT group (n=371) using the 30-day modified Rankin Scale.

Main Results:

  • Elevated serum cTnT was observed in 10.8% of AIS patients.
  • Higher National Institutes of Health Stroke Scale scores (indicating greater severity) were associated with elevated cTnT.
  • Insular lobe involvement and unfavorable 30-day outcomes were more frequent in the elevated cTnT group.

Conclusions:

  • Elevated cTnT in AIS is linked to severe neurological deficits and insular lobe damage.
  • Patients with AIS and elevated cTnT experience worse short-term prognoses compared to those with normal cTnT levels.
  • Further research is needed to elucidate the pathomechanisms connecting AIS and subclinical myocardial damage.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...